| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 08/22/2001 | EP1125577A2 Liquid drug delivery compositions |
| 08/22/2001 | EP1125576A1 Process for producing spherical fine particles containing drug |
| 08/22/2001 | EP1125575A1 Perfusate preparation for ophthalmic operation |
| 08/22/2001 | EP1125574A2 Cosmetical and pharmaceutical oil-in-water emulsions of polyether polysiloxanes |
| 08/22/2001 | EP1124959A1 Cell surface molecule-induced macrophage activation |
| 08/22/2001 | EP1124902A1 A membrane or matrix for controlling the permeation rate of drugs |
| 08/22/2001 | EP1124816A1 Products for body hygiene based on lapacho extracts containing quercitine, their preparation and use |
| 08/22/2001 | EP1124630A1 Method for preparing capsules consisting of a liquid active material core enclosed in a mineral coating |
| 08/22/2001 | EP1124603A1 Vaporizing device for administering sterile medication |
| 08/22/2001 | EP1124594A1 Implant with cavities containing therapeutic agents |
| 08/22/2001 | EP1124587A1 Hydrogel wound dressing containing liposome-encapsulated therapeutic agent |
| 08/22/2001 | EP1124582A1 Preservative system for topically administrable pharmaceutical compositions |
| 08/22/2001 | EP1124580A1 Enhanced radiation therapy |
| 08/22/2001 | EP1124567A2 Buffered compositions for dialysis |
| 08/22/2001 | EP1124563A2 Methods and compositions for the prevention of tolerance to medications |
| 08/22/2001 | EP1124556A1 Use of optically pure (r)-tofisopam for treating and preventing anxiety disorders and composition thereof |
| 08/22/2001 | EP1124551A2 Delta 9 tetrahydrocannabinol (delta 9 thc) solution metered dose inhalers and methods of use |
| 08/22/2001 | EP1124549A1 Water-miscible pharmaceutical compositions of paclitaxel |
| 08/22/2001 | EP1124544A1 Dry powder pharmaceutical formulation |
| 08/22/2001 | EP1124543A1 Controlled release formulation for water soluble drugs |
| 08/22/2001 | EP1124542A1 Capsules with porous mineral cortex |
| 08/22/2001 | EP1124541A1 Application of water-soluble or water-dispersible polymerizates which contain poly-ether and which are used as a coating agent, a binding agent and/or as a film-forming auxiliary agent in pharmaceutical forms of administration |
| 08/22/2001 | EP1124540A1 Dosage forms containing taste masked active agents |
| 08/22/2001 | EP1124539A1 Pharmaceutical formulation comprising omeprazole |
| 08/22/2001 | EP1124538A2 Composition for the parenteral administration of active agents |
| 08/22/2001 | EP1124537A1 Propofol composition |
| 08/22/2001 | EP1124536A1 Propofol composition comprising pentetate |
| 08/22/2001 | EP1124534A1 Expandable gastroretentive therapeutical system with prolonged stomach retention time |
| 08/22/2001 | EP1124443A1 Solid delivery systems for aroma ingredients |
| 08/22/2001 | EP1124440A2 Use of calcareous material for foodstuff and cosmetic material |
| 08/22/2001 | EP1104233A4 Improved film-forming compositions for protecting animal skin |
| 08/22/2001 | EP1085811A4 Broad specificity dna damage endonuclease |
| 08/22/2001 | EP0991402A4 Poly(vinyl alcohol) cryogel |
| 08/22/2001 | EP0973559B1 Method and composition for coating wound or protecting animal skin |
| 08/22/2001 | EP0907357A4 Non-aqueous controlled release pest and air care gel composition |
| 08/22/2001 | EP0862418B1 Method of producing morphologically uniform microcapsules and microcapsules produced by this method |
| 08/22/2001 | EP0836472B1 Therapeutic effervescent compositions |
| 08/22/2001 | EP0833611B1 A composition comprising an active agent dissolved in a glass-forming carrier and a process for the preparation thereof |
| 08/22/2001 | EP0831787B1 Composition for sustained release of human growth hormone |
| 08/22/2001 | EP0814766B1 Cosmetic and/or pharmaceutical preparations |
| 08/22/2001 | EP0696208B1 Oral drug delivery compositions |
| 08/22/2001 | EP0673255B1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 08/22/2001 | EP0641196B1 Microencapsulation of cells |
| 08/22/2001 | CN1309767A Method for controlling coating process |
| 08/22/2001 | CN1309666A Polymer composition of glucuronic acid glucosan |
| 08/22/2001 | CN1309642A Novel 1,2,5-trisubstd. 1,2-dihydro-indazol-3-ones with anti-asthmatic, anti-allergic, anti-inflammatory, immuno-modulating and neuro-protective effects, method for production and use as medicam ent |
| 08/22/2001 | CN1309626A Crystallization of xylitol, crystalline xylitol product and use thereof |
| 08/22/2001 | CN1309573A Apparatus for and methods of administering volatile substances into inhalation flow path |
| 08/22/2001 | CN1309570A Excipient |
| 08/22/2001 | CN1309561A Therapeutic agent for erection failure |
| 08/22/2001 | CN1309560A Prevention of migraine recurrence |
| 08/22/2001 | CN1309558A Transdermal patch and topical compositions comprising propylnorapomorphine |
| 08/22/2001 | CN1309557A Formulation contg. paroxetine |
| 08/22/2001 | CN1309556A Biodegradable sustained-release alginate gels |
| 08/22/2001 | CN1309555A Incorporation of active substances in carrier matrixes |
| 08/22/2001 | CN1309554A Biologically active composition |
| 08/22/2001 | CN1309553A Biologically active composition |
| 08/22/2001 | CN1308964A Process for preparing spirulina tablet |
| 08/22/2001 | CN1308958A Medicine 'Huoxuexingshen' for treating mental diseases (psychosis) |
| 08/22/2001 | CN1308940A Application and preparing process of nm-class biological medical stone powder |
| 08/22/2001 | CN1308937A Method for preparing microcapsule |
| 08/22/2001 | CN1308936A Granular Chinese medicine and its preparing process |
| 08/22/2001 | CN1308935A Medicinal patch for treating hepatism |
| 08/22/2001 | CN1069838C Stable microbubble suspensions as enhancement agent for ultrasound echography |
| 08/22/2001 | CN1069829C Percutaneous applied medicine contg. gestodene |
| 08/22/2001 | CN1069827C Polypeptide protein micro-beads medicine prepn. method |
| 08/22/2001 | CN1069826C Freezing-dried tetracaine hydrochloride powder injection |
| 08/22/2001 | CN1069825C Aqueous demethyl coclaurine injection for diagnosis of coronary heart disease |
| 08/22/2001 | CN1069815C Eucommia bark tea and preparing method thereof |
| 08/21/2001 | US6277892 Topical composition comprising sunless tanning agent and high molecular weight crosslinked cationic polymer based on dialkylaminoalkyl (meth)acrylate monomer or its quaternary ammonium or acid addition salt |
| 08/21/2001 | US6277891 Nitric oxide inhibits rhinovirus infection |
| 08/21/2001 | US6277890 Treatment of pulmonary disorders with retinoic acid or other retinoids by inducing formation of gas-exchange units (alveoli) |
| 08/21/2001 | US6277887 Methods for treating Parkinson's disease using optically pure (−)-bupropion |
| 08/21/2001 | US6277882 Skin disorders |
| 08/21/2001 | US6277869 Pharmaceutical composition |
| 08/21/2001 | US6277855 Method of treating dry eye disease with nicotinic acetylcholine receptor agonists |
| 08/21/2001 | US6277834 Agents for relieving side effects of adrenal cortex hormone |
| 08/21/2001 | US6277829 Dissolving azithromycin in solution of polybasic phosphate and citric acid; treatment of conjunctivitis, keratitis and blepharitis |
| 08/21/2001 | US6277828 Aqueous isotonic solutions containing human serum albumin, sodium chloride and citric acid, suitable for lyophilization, useful for the treatment of alzheimer's disease |
| 08/21/2001 | US6277827 Stability makes the novel species suitable for milling, compression and improved bioavailability; 2s-(4-(2, 5-dioxopyrrolidin-1-yl)-2s-mercaptobutyrylamino)-4-methylpenta noic acid (2,2-dimethyl-1s-methylcarbamoylpropyl)amide |
| 08/21/2001 | US6277413 Biodegradable compositions for the controlled release of encapsulated substances |
| 08/21/2001 | US6277412 A core and an enteric coating, the core including, as a pharmaceutical active compound, 5-aminosalicylic acid homogeneously dispersed in a non gel-forming polymer matrix which extends through the entire core |
| 08/21/2001 | US6277411 Pharmaceutical formulation containing DFMO for the treatment of cancer |
| 08/21/2001 | US6277410 Mixture comprises at least one block copolymer with ethylene(oxide) content of 50% or less, and at least one block copolymer with ethylene(oxide) content of 50% or more. |
| 08/21/2001 | US6277409 Molten composition comprising at least 50 weight percent of a thermoplastic material having a melting point of less than about 120 degrees c. is applied to the tablet, and solidified |
| 08/21/2001 | US6277406 Easily processed tablet compositions |
| 08/21/2001 | US6277405 Fenofibrate pharmaceutical composition having high bioavailability and method for preparing it |
| 08/21/2001 | US6277404 Applicable to the treatment of biological surfaces such as human skin or hair, animal skin or fur or the cuticle of plants or insects. |
| 08/21/2001 | US6277403 Poly(oxy(ethyl-1,2-ethanediyl)oxycarbonyl-1,4-phenyleneoxycarb onyl-1, 4-phenylenecarbonyloxy-1,4-phenylenecarbonyl or poly(oxy(decanyl-1,2-ethanediyl)oxycarbonyl-1,4-phenyleneoxyca rbonyl-1, 4-phenylenecarbonyloxy-1,4-phenylenecarbonyl) |
| 08/21/2001 | US6277401 Drug delivery device |
| 08/21/2001 | US6277400 Extendible transdermal therapeutic system |
| 08/21/2001 | US6277399 Composition incorporating bacterial phage associated lysing enzymes for treating dermatological infections |
| 08/21/2001 | US6277398 Analgesic drug composition containing a capsaicinoid and potentiator therefor |
| 08/21/2001 | US6277395 Swallowing-assistive drink |
| 08/21/2001 | US6277393 Systemic and/or local (topical) application of tetracycline and/or tetracycline derivative(s) for treating, suppressing and preventing of cerebrovascular diseases, traumas and damages of nervous system |
| 08/21/2001 | US6277391 Composition and method of treating diseases and disorders of the prostate |
| 08/21/2001 | US6277384 The amount of opioid antagonist included in the combination product provides at least a mildly negative, ?aversive? experience in physically dependent addicts (e.g., precipitated abstinence syndrome). |
| 08/21/2001 | US6277370 Pharmaceutical compositions containing lactobacilli for treatment of vaginal infections and related method |
| 08/21/2001 | US6277367 Erythropoietin solution preparation |
| 08/21/2001 | US6277366 Noncrosslinked quaternized aminoalkyl acrylate anion exchange resins, antilipemic agent |